Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Activated T Cells
16%
Anticancer Immune Response
100%
Antitumor Immune Response
16%
Breast Cancer
100%
CD20+ Cells
16%
CD3+
16%
CD68+
16%
CD8+
16%
CD8+ T Cells
16%
Dynamic Change
16%
Immune Infiltration
16%
Immune Microenvironment
100%
Immune Population
16%
Immune Response
16%
Low Diversity
16%
Lymph Node
16%
Lymphocyte Levels
16%
Metastatic Cancer Cells
16%
Monocytic Myeloid-derived Suppressor Cells (M-MDSCs)
16%
Neoadjuvant Chemotherapy
100%
Non-pathogenic
16%
Pathological Complete Response
50%
Peripheral Blood
16%
Post-neoadjuvant Chemotherapy
33%
Regulatory T Cells
16%
Response to Treatment
16%
T-cell Clonality
16%
Tumor
16%
Tumor Burden
16%
Tumor Microenvironment
33%
Tumor-infiltrating Lymphocytes
16%
Immunology and Microbiology
Activation of Immune Response
50%
CD20
50%
CD3 Antigen
50%
CD68
50%
CD8
50%
Clonal Variation
50%
Cytotoxic T-Cell
50%
Immune Cell Infiltration
50%
Immune Microenvironment
100%
Immune Response
50%
Lymph Node
50%
Myeloid
50%
Regulatory T Cell
50%
T Cell
100%
Tumor Volume
50%
Tumor-Infiltrating Lymphocytes
50%
INIS
balances
25%
blood
12%
breasts
100%
cancer
100%
chemotherapy
100%
dynamics
12%
levels
12%
luminal
12%
lymph nodes
12%
lymphocytes
12%
metastases
12%
patients
37%
populations
12%
surgery
12%
tumors
62%